# Efficacy and Safety of Tranexamic Acid in Adult Liver Transplantation---ESTA Trial

> **NCT07157631** · NA · RECRUITING · sponsor: **RenJi Hospital** · enrollment: 1546 (estimated)

## Conditions studied

- Liver Transplantation
- Tranexamic Acid
- End-stage Liver Disease (ESLD)

## Interventions

- **DRUG:** tranexamic acid
- **DRUG:** 0.9 % saline

## Key facts

- **NCT ID:** NCT07157631
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-01
- **Primary completion:** 2027-11-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 1546 (ESTIMATED)
- **Last updated:** 2025-12-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07157631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07157631, "Efficacy and Safety of Tranexamic Acid in Adult Liver Transplantation---ESTA Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07157631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*